KM Financial Solutions | Novartis readies to auction U.S. generic pills business -sources
10157
post-template-default,single,single-post,postid-10157,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Novartis readies to auction U.S. generic pills business -sources

Novartis readies to auction U.S. generic pills business -sources

Feb 16 (Reuters) – Switzerland’s Novartis AG is
preparing to auction its U.S. generic pill business, looking to
shed a unit that has struggled amid fierce price competition,
people familiar with the matter said on Friday.

No Comments

Sorry, the comment form is closed at this time.